# Barclays Bank PLC Q3 2025 Pillar 3 Report
**30 September 2025**

## Table of Contents

| Barclays Bank PLC Pillar 3 | Page |
| :--- | :--- |
| **Notes** | |
| Forward-looking statements | 3 |
| **Introduction** | |
| Disclosure Background | 4 |
| **Summary** | |
| KM1 – Key Metrics | 5 |
| **Risk weighted assets (RWAs)** | |
| RWAs by risk type | 7 |
| OV1 – Overview of risk weighted exposure amounts | 8 |
| CR8 - RWEA flow statements of credit risk exposures under the IRB approach | 9 |
| CCR7 - RWEA flow statements of counterparty credit risk exposures under the IMM | 9 |
| MR2-B - RWA flow statements of market risk exposures under the IMA | 10 |
| **Liquidity** | |
| LIQ1 - Liquidity Coverage Ratio | 11 |

---

## Notes

The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary available at home.barclays/investor-relations/reports-and-events.

### Forward-looking statements

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Barclays Bank Group. The Barclays Bank Group cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Barclays Bank Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Barclays Bank Group's future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance ("ESG") commitments and targets), plans and objectives for future operations, International Financial Reporting Standards ("IFRS") and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); changes in tax laws and practice; the outcome of current and future legal proceedings and regulatory investigations; the Barclays Bank Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in which climate policy is implemented in the regions where the Barclays Bank Group operates, including as a result of the adoption of anti-ESG rules and regulations, or other forms of governmental and regulatory action against ESG policies; environmental, social and geopolitical risks and incidents and similar events beyond the Barclays Bank Group's control; financial crime; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Barclays Bank Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences of the conflicts in Ukraine and the Middle East on European and global macroeconomic conditions, political stability and financial markets; changes in US legislation and policy following the US elections in 2024; developments in the UK's relationship with the European Union; the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Barclays Bank Group's reputation, business or operations; the Barclays Bank Group's ability to access funding; and the success of acquisitions, disposals, joint ventures and other strategic transactions. A number of these factors are beyond the Barclays Bank Group's control. As a result, the Barclays Bank Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Barclays Bank Group's forward-looking statements. Additional risks and factors which may impact the Barclays Bank Group's future financial condition and performance are identified in Barclays Bank PLC's filings with the US Securities and Exchange Commission ("SEC") (including, without limitation, Barclays Bank PLC's Annual Report on Form 20-F for the financial year ended 31 December 2024), which are available on the SEC's website at www.sec.gov.

Subject to Barclays Bank PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

---

## Introduction

### Disclosure Background

Barclays Bank PLC is a wholly-owned subsidiary of Barclays PLC and is the non ring-fenced bank within the Barclays PLC Group.

Barclays Bank PLC capital requirements are set by the Prudential Regulation Authority (PRA) at a solo-consolidated level. Barclays Bank PLC solo-consolidated comprises Barclays Bank PLC, the parent, plus certain additional subsidiaries, whose inclusion within the consolidation is subject to PRA approval. The disclosures provided in this document for Barclays Bank PLC are based on this regulatory scope of consolidation. This differs from the accounting disclosures, where Barclays Bank PLC Group refers to Barclays Bank PLC, the parent, and all its subsidiaries.

For the purpose of liquidity management, Barclays Bank PLC and its subsidiary Barclays Capital Securities Limited, a UK broker dealer entity, are monitored on a combined basis by the PRA under a Domestic Liquidity Sub-Group arrangement ('DoLSub') (Barclays Bank PLC DoLSub). The liquidity disclosures (Liquidity Coverage Ratio and Net Stable Funding Ratio) provided in this document for Barclays Bank PLC are based on this regulatory scope of consolidation, unless otherwise specified.

The terms Risk Weighted Asset (RWA) and Risk Weighted Exposure Amount (RWEA) are used interchangeably throughout the document.

Leverage minimum requirements are set at the sub-consolidated level for Barclays Bank PLC. The sub-consolidated group represents the Barclays Bank PLC Group on a regulatory scope of consolidation per PRA approval. As a result, the Barclays Bank PLC leverage disclosures contained within this document are presented on both the Barclays Bank PLC solo-consolidated basis and Barclays Bank PLC sub-consolidated basis. Capital and Risk Weighted Assets disclosure requirements remain set at the Barclays Bank PLC solo-consolidated level.

The Pillar 3 report is prepared in accordance with the Capital Requirements Regulation (CRR) and the PRA Rulebook. In particular, the Disclosure (CRR) Part of the PRA Rulebook specifies the requirements of the Pillar 3 framework.

The disclosures included in this report reflect Barclays Bank PLC's interpretation of the current rules and guidance.

---

## Summary

### Table 1: KM1 - Key metrics - Part 1

This table shows key regulatory metrics and ratios as well as related components such as own funds, RWAs, capital ratios, capital buffer requirements, leverage ratio, Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR) and additional requirements based on Supervisory Review and Evaluation Process (SREP). Part 2 of this table further includes UK LR2 components which are required to be reported with a quarterly frequency as per Article 433a(4) of the Disclosure (CRR) Part of the PRA Rulebook for Barclays Bank Group and Barclays Bank PLC.

| KM1 ref | | 30.09.25 £m | 30.06.25 £m | 31.03.25 £m | 31.12.24 £m | 30.09.24 £m |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| | Available own funds (amounts) | | | | | |
| 1 | Common Equity Tier 1 (CET1) capital¹ | 27,586 | 27,763 | 27,646 | 26,995 | 25,996 |
| 2 | Tier 1 (T1) capital¹ | 35,276 | 35,493 | 35,648 | 33,787 | 32,954 |
| 3 | Total capital ¹,² | 41,401 | 41,296 | 42,297 | 40,444 | 40,240 |
| | Risk-weighted exposure amounts | | | | | |
| 4 | Total risk-weighted exposure amount¹ | 223,887 | 219,137 | 219,021 | 223,648 | 208,376 |
| | Capital ratios (as a percentage of risk-weighted exposure amount) | | | | | |
| 5 | Common Equity Tier 1 ratio (%)¹ | 12.3% | 12.7% | 12.6% | 12.1% | 12.5% |
| 6 | Tier 1 ratio (%)¹ | 15.8% | 16.2% | 16.3% | 15.1% | 15.8% |
| 7 | Total capital ratio (%) ¹,² | 18.5% | 18.8% | 19.3% | 18.1% | 19.3% |
| | Additional own funds requirements based on SREP (as a percentage of risk-weighted exposure amount) | | | | | |
| UK 7a | Additional CET1 SREP requirements (%) | 2.6% | 2.8% | 2.8% | 2.8% | 2.8% |
| UK 7b | Additional AT1 SREP requirements (%) | 0.9% | 0.9% | 0.9% | 0.9% | 0.9% |
| UK 7c | Additional T2 SREP requirements (%) | 1.2% | 1.3% | 1.3% | 1.3% | 1.3% |
| UK 7d | Total SREP own funds requirements (%) | 12.7% | 13.1% | 13.1% | 13.1% | 13.1% |
| | Combined buffer requirement (as a percentage of risk-weighted exposure amount) | | | | | |
| 8 | Capital conservation buffer (%) | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
| 9 | Institution specific countercyclical capital buffer (%) | 0.8% | 0.8% | 0.8% | 0.7% | 0.7% |
| 11 | Combined buffer requirement (%) | 3.3% | 3.3% | 3.3% | 3.3% | 3.2% |
| UK 11a | Overall capital requirements (%) | 16.0% | 16.3% | 16.3% | 16.3% | 16.2% |
| 12 | CET1 available after meeting the total SREP own funds | 5.2% | 5.3% | 5.3% | 4.7% | 5.1% |

**Notes**
1. 2024 comparatives for Capital and RWAs have been calculated applying the IFRS 9 transitional arrangements in accordance with the CRR. Effective from 1 January 2025, these IFRS 9 transitional arrangements no longer applied.
2. 2024 and Q1 2025 comparatives for total capital have been calculated applying the grandfathering of CRR non-compliant capital instruments included within Tier 2 capital. Effective from 29 June 2025, these instruments no longer qualified as Tier 2 Capital.

The CET1 ratio increased by c.20bps to 12.3% (December 2024: 12.1%) as CET1 capital increased by £0.6bn to £27.6bn partially offset by an increase in RWAs of £0.2bn to £223.9bn:
* c.130bps increase from attributable profit generated in the period
* c.110bps decrease due to dividends paid and foreseen
* c.30bps increase from other CET1 capital movements, due to lower capital deductions and an increase in the fair value through other comprehensive income reserve
* c.30bps decrease as a result of a £5.0bn increase in RWAs, excluding the impact of foreign exchange movements, primarily driven by higher client lending limits and growth in lending balances in the UK Corporate Bank (UKCB)
* A £0.8bn decrease in CET1 capital due to a decrease in the currency translation reserve partially offset by a £4.8bn decrease in RWA due to the strengthening of spot GBP against USD

### Table 1: KM1 - Key metrics - Part 2

| KM1 ref | LR 2 Ref | Leverage ratio | | | | | |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| | Barclays Bank PLC sub-consolidated group¹ | 30.09.25 £m | 30.06.25 £m | 31.03.25 £m | 31.12.24 £m | 30.09.24 £m |
| 13 | | Total exposure measure excluding claims on central banks² | 1,017,430 | 991,396 | 989,399 | 946,809 | 947,527 |
| 14 | 25 | Leverage ratio excluding claims on central banks (%) 2,4 | 5.5% | 5.6% | 5.6% | 5.8% | 5.7% |
| | Additional leverage ratio disclosure requirements | | | | | |
| UK 14a | UK 25a | Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%)³ | 5.5% | 5.6% | 5.6% | 5.8% | 5.6% |
| UK 14b | UK 25c | Leverage ratio including claims on central banks (%)² | 4.5% | 4.6% | 4.6% | 4.8% | 4.7% |
| UK 32 | | Average total exposure measure excluding claims on central banks 2,5 | 1,071,343 | 1,057,533 | 1,078,084 | 1,050,090 | 1,029,452 |
| UK 14c | UK 34 | Average leverage ratio excluding claims on central banks (%) 2,5 | 5.2% | 5.2% | 5.1% | 5.2% | 5.2% |
| UK 14d | UK 33 | Average leverage ratio including claims on central banks (%) 2,5 | 4.3% | 4.3% | 4.3% | 4.4% | 4.3% |
| UK 27 | | Leverage ratio buffer (%)⁴ | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| UK 14e | UK 27b | Of which: Countercyclical leverage ratio buffer (%)⁴ | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| | Barclays Bank PLC solo-consolidated | | | | | |
| 13 | | Total exposure measure excluding claims on central banks² | 893,470 | 874,304 | 869,944 | 831,060 | 792,811 |
| 14 | 25 | Leverage ratio excluding claims on central banks (%)² | 3.9% | 4.1% | 4.1% | 4.1% | 4.2% |
| | Additional leverage ratio disclosure requirements | | | | | |
| UK 14a | UK 25a | Fully loaded ECL accounting model leverage ratio excluding claims on central banks (%)³ | 3.9% | 4.1% | 4.1% | 4.1% | 4.2% |
| UK 14b | UK 25c | Leverage ratio including claims on central banks (%)² | 3.3% | 3.4% | 3.4% | 3.4% | 3.4% |
| | Liquidity Coverage Ratio | | | | | |
| 15 | | Total high-quality liquid assets (HQLA) (Weighted value)⁷ | 210,586 | 207,132 | 204,665 | 201,875 | 204,664 |
| UK 16a | | Cash outflows - Total weighted value | 338,989 | 318,872 | 313,916 | 300,363 | 285,960 |
| UK 16b | | Cash inflows - Total weighted value⁷ | 198,773 | 183,740 | 177,288 | 163,579 | 145,612 |
| 16 | | Total net cash outflows (adjusted value)⁷ | 140,215 | 135,132 | 136,627 | 136,784 | 140,348 |
| 17 | | Liquidity coverage ratio (%) 6,7 | 151.1% | 153.8% | 150.1% | 147.9% | 146.1% |
| | Net Stable Funding Ratios | | | | | |
| 18 | | Total available stable funding | 378,825 | 377,260 | 380,291 | 372,381 | 366,494 |
| 19 | | Total required stable funding | 334,217 | 330,485 | 330,876 | 332,874 | 329,532 |
| 20 | | NSFR ratio (%) | 113.4% | 114.2% | 114.9% | 111.9% | 111.3% |

**Notes**
1. The Barclays Bank PLC solo-consolidated and Barclays Bank PLC sub-consolidated CET1 ratios, as are relevant for assessing against the conversion triggers in Barclays Bank PLC AT1 securities (all of which are held by Barclays PLC), were 12.3% and 16.9% respectively.
2. 2024 comparatives for UK leverage measures have been calculated by applying the IFRS 9 transitional arrangements in accordance with the CRR. Effective from 1 January 2025, these IFRS9 transitional arrangements no longer applied.
3. 2024 comparatives for fully loaded UK leverage ratios have been calculated without applying the IFRS 9 transitional arrangements in accordance with the CRR. Effective from 1 January 2025, these IFRS9 transitional arrangements no longer applied.
4. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement and countercyclical leverage ratio buffer (CCLB) must be covered solely with CET1 capital. The CET1 capital held against the 0.2% CCLB was £2bn.
5. Average UK leverage ratio uses capital based on the last day of each month in the quarter and an exposure measure for each day in the quarter.
6. The LCR is computed as an average of the last 12 month-end ratios. From June 2025 Barclays has prospectively implemented a new methodology for calculating net stress outflows related to secured financing transactions in the liquidity coverage ratio.
7. Prior period comparatives have been re-presented to reflect a change to the calculation of outflows from certain secured financing transactions that was adopted from Q1 2025.
8. The NSFR is computed as an average of the last four spot quarter-end positions.

The Barclays Bank PLC sub-consolidated group UK leverage ratio decreased to 5.5% (December 2024: 5.8%) as the leverage exposure increased by £70.6bn to £1,017.4bn (December 2024: £946.8bn) partially offset by an increase of £1.4bn in Tier 1 capital. The increase in leverage exposure was largely driven by an increase in trading activity in the Investment Bank (IB), partially offset by the strengthening of spot GBP against USD.

The average LCR for the 12 months to 30 September 2025 increased to 151.1% (December 2024: 147.9%), primarily driven by an increase in High Quality Liquid Assets (HQLA) relative to net cash outflows versus the year-end position.

The average NSFR for the four quarter ends to 30 September 2025 was 113.4% (December 2024: 111.9%), equivalent to a surplus of £44.6bn (December 2024: £39.5bn) above the 100% regulatory requirement.

---

## Risk weighted assets

### Table 2: RWAs by risk type

This table shows RWAs by risk type.

| | Credit risk | Counterparty credit risk | Settlement risk | Market risk | Operational risk | Total RWAS |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| | Std | A-IRB | Std | A-IRB | CVA | Std | IMA | | | |
| | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| **As at 30.09.25** | | | | | | | | | | |
| Barclays Bank PLC | 67,897 | 63,100 | 22,991 | 17,253 | 47 | 1,939 | 6,340 | 21,942 | 22,378 | 223,887 |
| **As at 31.12.24** | | | | | | | | | | |
| Barclays Bank PLC | 64,126 | 62,948 | 24,438 | 19,493 | 115 | 1,938 | 5,857 | 22,315 | 22,418 | 223,648 |

---

### Table 3: OV1 – Overview of risk weighted exposure amounts

The table shows RWAs and minimum capital requirement by risk type and approach.

| | Credit risk (excluding CCR) | | | Counterparty credit risk - CCR | | | | Market risk | | Total own funds requirements |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| | Risk weighted exposure amounts (RWEAS) | | | | | | | | | |
| | As at 30.09.25 | As at 30.06.25 | As at 31.12.24 | As at 30.09.25 | As at 30.06.24 | As at 31.12.24 | As at 30.09.25 | As at 30.06.24 | As at 31.12.24 | As at 30.09.25 | As at 30.06.24 | As at 31.12.24 |
| | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m |
| 1 | | 108,134 | 104,830 | 106,697 | | | | 8,651 | 8,386 | 8,536 | | |
| 2 | Of which the standardised approach | 56,195 | 54,111 | 54,722 | | | | 4,496 | 4,329 | 4,378 | | |
| 4 | Of which: slotting approach | 4,110 | 4,009 | 3,628 | | | | 329 | 290 | 321 | | |
| 5 | Of which the advanced IRB (AIRB) approach | 47,829 | 46,697 | 48,347 | | | | 3,736 | 3,868 | 3,667 | | |
| 6 | Counterparty credit risk - CCR | 42,111 | 44,759 | 45,839 | | | | 3,582 | 3,667 | 3,582 | | |
| 7 | Of which the standardised approach | 3,998 | 3,917 | 3,812 | | | | 320 | 313 | 305 | | |
| 8 | Of which internal model method | 28,574 | 29,757 | 31,769 | | | | 2,286 | 2,381 | 2,542 | | |
| UK 8a | Of which exposures to a CCP | 1,710 | 1,544 | 1,267 | | | | 137 | 124 | 101 | | |
| UK 8b | Of which credit valuation adjustment - CVA | 1,939 | 2,982 | 1,938 | | | | 155 | 239 | 155 | | |
| 9 | Of which other CCR | 5,890 | 6,559 | 7,053 | | | | 471 | 525 | 564 | | |
| 15 | Settlement risk | 47 | 329 | 115 | | | | 4 | 26 | 9 | | |
| 16 | Securitisation exposures in the non-trading book (after the cap) | 22,935 | 19,750 | 20,407 | | | | 1,835 | 1,580 | 1,633 | | |
| 17 | Of which SEC-IRBA approach | 11,162 | 10,678 | 10,973 | | | | 893 | 854 | 878 | | |
| 18 | Of which SEC-ERBA (including IAA) | 3,159 | 1,947 | 2,239 | | | | 253 | 156 | 179 | | |
| 19 | Of which SEC-SA approach | 8,562 | 7,046 | 7,174 | | | | 685 | 564 | 574 | | |
| UK 19a | Of which 1250%/ deduction | 52 | 79 | 21 | | | | 4 | 6 | 2 | | |
| 20 | Position, foreign exchange and commodities risks (Market risk) | 28,282 | 27,091 | 28,172 | | | | 2,262 | 2,167 | 2,254 | | |
| 21 | Of which the standardised approach | 6,340 | 4,749 | 5,857 | | | | 507 | 380 | 469 | | |
| 22 | Of which IMA | 21,942 | 22,342 | 22,315 | | | | 1,755 | 1,787 | 1,785 | | |
| 23 | Operational risk | 22,378 | 22,378 | 22,418 | | | | 1,790 | 1,790 | 1,793 | | |
| UK 23b | Of which standardised approach | 22,378 | 22,378 | 22,418 | | | | 1,790 | 1,790 | 1,793 | | |
| 24 | Amounts below the thresholds for deduction (subject to 250% risk weight) (For information only) | 10,346 | 10,413 | 10,126 | | | | 828 | 833 | 810 | | |
| 29 | Total | 223,887 | 219,137 | 223,648 | | | | 17,911 | 17,531 | 17,892 | | |

Total RWAs increased by £4.8bn in the quarter to £223.9bn (June 2025: £219.1bn) primarily due to increased lending in the UK Corporate Bank and foreign exchange movements due to the depreciation of GBP against USD.

### Table 4: CR8 - RWEA flow statements of credit risk exposures under the IRB approach

The total in this table shows the contribution of credit risk RWAs under the AIRB approach and will not directly reconcile to the Credit Risk AIRB RWAs in table 3.

| | Three months ended 30 September 2025 £m | Nine months ended 30 September 2025 £m |
| :--- | :--- | :--- |
| 1 | Risk weighted exposure amount as at the end of the previous reporting period | 49,404 | 50,463 |
| 2 | Asset size | 954 | 1,392 |
| 3 | Asset quality | 2 | 88 |
| 4 | Model updates | | 304 |
| 5 | Methodology and policy | — | (366) |
| 6 | Acquisitions and disposals | | |
| 7 | Foreign exchange movements | 452 | (1,069) |
| 8 | Other | | |
| 9 | Risk weighted exposure amount as at the end of the reporting period | 50,812 | 50,812 |

Advanced credit risk RWAs increased by £1.4bn to £50.8bn in the quarter (June 2025: £49.4bn) primarily driven by a £1.0bn increase in asset size primarily driven by business activity in IB.

Advanced credit risk RWAs increased by £0.3bn to £50.8bn in the year (December 2024: £50.5bn) primarily driven by a £1.4bn increase in asset size due to lending growth in UKCB partially offset by a £1.1bn decrease in foreign exchange movements due to the strengthening of spot GBP against USD.

### Table 5: CCR7 - RWEA flow statements of CCR exposures under the IMM

The total in this table shows the contribution of Internal Model Method (IMM) exposures to CCR RWAs (under both standardised and AIRB) and will not directly reconcile to the CCR AIRB RWAs in table 3. RWEA changes due to IRB models are included in 'Credit quality of counterparties'.

| | Three months ended 30 September 2025 £m | Nine months ended 30 September 2025 £m |
| :--- | :--- | :--- |
| 1 | Risk weighted exposure amount as at the end of the previous reporting period | 29,757 | 31,769 |
| 2 | Asset size | (1,517) | (2,040) |
| 3 | Credit quality of counterparties | (106) | (211) |
| 4 | Model updates (IMM only) | — | — |
| 5 | Methodology and policy (IMM only) | — | — |
| 6 | Acquisitions and disposals | 440 | (944) |
| 7 | Foreign exchange movements | | |
| 8 | Other | 28,574 | 28,574 |
| 9 | Risk weighted exposure amount as at the end of the reporting period | | |

IMM RWAs decreased by £1.2bn to £28.6bn in the quarter (June 2025: £29.8bn) driven by a £1.5bn decrease in asset size primarily driven by client and trading activity in IB.

IMM RWAs decreased by £3.2bn to £28.6bn in the year (December 2024: £31.8bn) driven by:
* A £2.0bn decrease in asset size primarily driven by client and trading activity in IB
* A £0.9bn decrease in foreign exchange movements due to strengthening of spot GBP against USD

### Table 6: MR2-B – RWA flow statements of market risk exposures under the IMA

This table shows the contribution of market risk RWAs covered by internal models (i.e. value at risk (VaR), stressed value at risk (SVaR) and incremental risk charge (IRC)).

**Three months ended 30 September 2025**

| | VaR £m | SVaR £m | IRC £m | Other £m | Total RWA £m | Total own funds requirements £m |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | RWAs at previous period end | 3,662 | 10,682 | 3,943 | 4,055 | 22,342 | 1,787 |
| 1a | Regulatory adjustment¹ | (2,011) | (5,738) | | (7,749) | (620) |
| 1b | RWAs at the previous quarter-end (end of the day) | 1,651 | 4,944 | 3,943 | 4,055 | 14,593 | 1,167 |
| 2 | Movement in risk levels | (204) | (109) | (332) | (70) | (715) | (57) |
| 3 | Model updates/changes | — | — | — | — | — | |
| 4 | Methodology and policy | — | — | — | — | — | |
| 5 | Acquisitions and disposals | — | — | — | — | — | |
| 8a | RWAs at the end of the disclosure period (end of the day) | 1,447 | 4,835 | 3,611 | 3,985 | 13,878 | 1,110 |
| 8b | Regulatory adjustment² | 1,732 | 6,332 | | | 8,064 | 645 |
| 8 | RWAs at the end of the disclosure period | 3,179 | 11,167 | 3,611 | 3,985 | 21,942 | 1,755 |

**Notes**
1. Row 1a reflects the difference between reported RWA (row 1) and the relevant spot measure (row 1b) for the previous period.
2. Row 8b reflects the difference between the relevant spot measure (row 8a) and reported RWA (row 8) for the current period.

Modelled Market risk RWAs remained stable at £21.9bn in the quarter (June 2025: £22.3bn).

**Nine months ended 30 September 2025**

| | VaR £m | SVaR £m | IRC £m | Other £m | Total RWA £m | Total own funds requirements £m |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | RWAs at previous period end | 3,903 | 9,218 | 5,327 | 3,867 | 22,315 | 1,785 |
| 1a | Regulatory adjustment¹ | (2,032) | (4,085) | (61) | | (6,178) | (494) |
| 1b | RWAs at the previous quarter-end (end of the day) | 1,871 | 5,133 | 5,266 | 3,867 | 16,137 | 1,291 |
| 2 | Movement in risk levels | (424) | (298) | (1,655) | 118 | (2,259) | (181) |
| 3 | Model updates/changes | — | — | — | — | — | |
| 4 | Methodology and policy | — | — | — | — | — | |
| 5 | Acquisitions and disposals | — | — | — | — | — | |
| 8a | RWAs at the end of the disclosure period (end of the day) | 1,447 | 4,835 | 3,611 | 3,985 | 13,878 | 1,110 |
| 8b | Regulatory adjustment² | 1,732 | 6,332 | | | 8,064 | 645 |
| 8 | RWAs at the end of the disclosure period | 3,179 | 11,167 | 3,611 | 3,985 | 21,942 | 1,755 |

**Notes**
1. Row 1a reflects the difference between reported RWA (row 1) and the relevant spot measure (row 1b) for the previous period.
2. Row 8b reflects the difference between the relevant spot measure (row 8a) and reported RWA (row 8) for the current period.

Modelled Market risk RWAs remained stable at £21.9bn in the year (December 2024: £22.3bn).

---

## Liquidity

### Table 7: LIQ1 - Liquidity Coverage Ratio

This table shows the level and components of the Liquidity Coverage Ratio (LCR).

#### LIQ1 - Liquidity coverage ratio (average)

| | Total unweighted value (average) | | | | | Total weighted value (average) | | | |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| | 30.09.25 £m | 30.06.25 £m | 31.03.25 £m | 31.12.24 £m | 30.09.25 £m | 30.06.25 £m | 31.03.25 £m | 31.12.24 £m |
| UK1a | Number of data points used in calculation of averages¹ | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| **High-quality liquid assets** | | | | | | | | |
| UK1b | Total high-quality liquid assets (HQLA) | £m | £m | £m | £m | £m | £m | £m | £m |
| 1 | | | | | | 210,586 | 207,132 | 204,665 | 201,875 |
| **Cash outflows** | | | | | | | | |
| 2 | Retail deposits and deposits from small business customers, of which: | 30,045 | 29,951 | 30,034 | 29,688 | 3,323 | 3,274 | 3,235 | 3,156 |
| 3 | Stable deposits | 792 | 783 | 766 | 752 | 40 | 39 | 38 | 38 |
| 4 | Less stable deposits | 19,791 | 19,312 | 19,133 | 18,740 | 3,283 | 3,235 | 3,197 | 3,117 |
| 5 | Unsecured wholesale funding, of which: | 198,178 | 195,922 | 195,737 | 193,654 | 91,666 | 90,874 | 92,764 | 93,370 |
| 6 | Operational deposits (all counterparties) and deposits in networks of cooperative banks | 83,920 | 82,936 | 80,982 | 78,635 | 20,797 | 20,553 | 20,071 | 19,492 |
| 7 | Non-operational deposits (all counterparties)² | 112,347 | 110,722 | 111,514 | 111,205 | 68,957 | 68,057 | 69,452 | 70,064 |
| 8 | Unsecured debt | 1,911 | 2,264 | 3,241 | 3,814 | 1,912 | 2,264 | 3,241 | 3,814 |
| 9 | Secured wholesale funding | | | | | 117,668 | 100,360 | 95,164 | 92,568 |
| 10 | Additional requirements, of which: | 168,733 | 169,056 | 168,626 | 167,558 | 55,534 | 57,180 | 56,863 | 56,919 |
| 11 | Outflows related to derivative exposures and other collateral requirements | 25,976 | 27,053 | 26,653 | 26,895 | 19,732 | 20,782 | 20,279 | 20,685 |
| 12 | Outflows related to loss of funding on debt products | 5,279 | 5,580 | 5,478 | 5,464 | 5,279 | 5,581 | 5,478 | 5,464 |
| 13 | Credit and liquidity facilities | 137,478 | 136,423 | 136,495 | 135,199 | 30,523 | 30,817 | 31,106 | 30,770 |
| 14 | Other contractual funding obligations | 63,596 | 63,065 | 62,839 | 51,375 | 62,853 | 62,323 | 62,097 | 50,638 |
| 15 | Other contingent funding obligations | 89,164 | 82,404 | 78,538 | 76,894 | 7,945 | 4,861 | 3,793 | 3,712 |
| 16 | Total cash outflows | 338,989 | 318,872 | 313,916 | 300,363 | | | | |
| **Cash inflows** | | | | | | | | |
| 17 | Secured lending (e.g. reverse repos) | 800,156 | 780,772 | 770,954 | 743,866 | 107,062 | 93,147 | 88,411 | 85,974 |
| 18 | Inflows from fully performing exposures | 25,718 | 24,856 | 24,026 | 23,572 | 22,496 | 21,748 | 21,168 | 20,714 |
| 19 | Other cash inflows³ | 72,232 | 71,698 | 70,459 | 59,353 | 69,215 | 68,845 | 67,709 | 56,891 |
| 20 | Total cash inflows⁴ | 898,106 | 877,326 | 865,439 | 826,791 | 198,773 | 183,740 | 177,288 | 163,579 |
| UK-20c | Inflows subject to 75% cap⁴ | 761,213 | 745,568 | 735,859 | 701,891 | 198,773 | 183,740 | 177,288 | 163,579 |
| UK-21 | Liquidity buffer⁴ | | | | | 210,586 | 207,132 | 204,665 | 201,875 |
| 22 | Total net cash outflows⁴ | | | | | 140,215 | 135,132 | 136,627 | 136,784 |
| 23 | Liquidity coverage ratio (%) (average)⁴ | | | | | 151.1% | 153.8% | 150.1% | 147.9% |

**Notes**
1. LCR is computed as an average of the last 12 spot month end ratios. From June 2025 Barclays has prospectively implemented a new methodology for calculating net stress outflows related to secured financing transactions in the liquidity coverage ratio.
2. Non-operational deposits in row 7 also include excess operational deposits as defined in Article 27(4) of the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook.
3. Difference between total weighted inflows and total weighted outflows arising from transactions in third countries where there are transfer restrictions or which are denominated in non-convertible currencies.
4. Prior period comparatives have been re-presented to reflect a change to the calculation of outflows from certain secured financing transactions that was adopted from Q1 2025.

#### Table 7: LIQ1 - Liquidity Coverage Ratio (continued)

The average LCR for the 12 months to 30 September 2025 was 151.1% (June 2025: 153.8%), equivalent to a surplus of £70.4bn (June 2025: £72.0bn) above the 100% regulatory requirement.

The composition of the liquidity pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration risk by issuer, currency and asset type. Given the returns generated by these highly liquid assets, the risk and reward profile is continuously managed.

The strong deposit franchise is a primary funding source for Barclays Bank PLC. Barclays Bank PLC continued to issue in the shorter-term markets and maintained active medium-term note programmes. This funding capacity enables Barclays Bank PLC to maintain their stable and diversified funding base.

Barclays Bank PLC also support various central bank monetary initiatives, such as the Bank of England's Term Funding Scheme with additional incentives for SMEs (TFSME). These are reported under 'repurchase agreements and other similar secured borrowing' on the balance sheet.